University of Manitoba-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2017

  1. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study

    Neurourology and Urodynamics, Vol. 36, Núm. 2, pp. 368-375

  2. Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivity

    BJU International, Vol. 119, Núm. 6, pp. 926-932